Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells

Excess hepatic lipid accumulation is the hallmark of non-alcoholic fatty liver disease (NAFLD), for which no medication is currently approved. However, glucagon-like peptide-1 receptor agonists (GLP-1RAs), already approved for treating type 2 diabetes, have lately emerged as possible treatments. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalifa, Olfa, Ouararhni, Khalid, Errafii, Khaoula, Alajez, Nehad M., Arredouani, Abdelilah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380891/
https://www.ncbi.nlm.nih.gov/pubmed/37511368
http://dx.doi.org/10.3390/ijms241411606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380891/
https://www.ncbi.nlm.nih.gov/pubmed/37511368
http://dx.doi.org/10.3390/ijms241411606

Ejemplares similares